
Join to view full profile
15715 S 46th StSte 100Phoenix, AZ 85048
Phone+1 480-961-2365
Fax+1 480-961-2382
Dr. Weidman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
West Virginia UniversityResidency, Neurology, 1991 - 1992
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Neurology, 1987 - 1990
State University of New York Downstate Medical Center College of MedicineClass of 1987
Certifications & Licensure
AZ State Medical License 1998 - 2027
PA State Medical License 1988 - 1998
FL State Medical License 1994 - 1996
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012, 2014
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Clinical Trials
- A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ) Start of enrollment: 2017 Dec 18
Publications & Presentations
PubMed
- Neuropsychological Functioning in Cognitively Normal, Older American Indians of the Southwestern United States.Brittany Cerbone, Krista D Hanson, Vicky T Lomay, Meredith Wicklund, David A Weidman
Archives of Clinical Neuropsychology. 2025-07-25 - 4 citationsSelf-Supervised Contrastive Learning to Predict the Progression of Alzheimer's Disease with 3D Amyloid-PET.Min Gu Kwak, Yi Su, Kewei Chen, David Weidman, Teresa Wu
Bioengineering. 2023-09-28 - 4 citationsA Novel Transfer Learning Model for Predictive Analytics using Incomplete Multimodality Data.Xiaonan Liu, Kewei Chen, David Weidman, Teresa Wu, Fleming Lure
IISE Transactions. 2021-01-01
Press Mentions
What Drugmakers Did Not Tell Volunteers in Alzheimer’s TrialsOctober 23rd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: